Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Epstein

Showing results (231-240 of 1,865) with videos related to

Pageof 187
Sort By:
The American Journal of Medicine|March 30, 1987
Renal hemodynamic effects of calcium antagonistsR D Loutzenhiser, M Epstein
JAMA|June 23, 1989
Case mix and resource utilization by uninsured hospital patients in the Boston metropolitan areaJ Weissman, A M Epstein
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
Arterial calcification and calcium antagonists: what does it mean?M Epstein, H R Black
Molecular & Cellular Oncology|November 25, 2020
Tumorigenic de-differentiation: the alternative splicing wayDebleena Ray, David M Epstein
Heartrhythm Case Reports|May 7, 2020
Author's Reply-Is it really COVID-19?David Chang, Laurence M Epstein
The Journal of Innovations in Cardiac Rhythm Management|June 5, 2020
Strategies for Transvenous Lead Extraction ProceduresLaurence M Epstein, Melanie Maytin
Journal of Hypertension|February 12, 1998
Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal diseaseR A Preston, M Epstein
JAMA|November 6, 1987
Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramineG Oster, A M Epstein
Heartrhythm Case Reports|May 12, 2017
ICD lead abandonment is without risk? A case of "lead on lead crime"Jacques Rizkallah, Laurence M Epstein
Heart (British Cardiac Society)|February 8, 2011
The challenges of transvenous lead extractionMelanie Maytin, Laurence M Epstein
Pageof 187

Showing results (231-240 of 1,865) with videos related to

Sort By:
Pageof 187
The American Journal of Medicine|March 30, 1987
Renal hemodynamic effects of calcium antagonistsR D Loutzenhiser, M Epstein
JAMA|June 23, 1989
Case mix and resource utilization by uninsured hospital patients in the Boston metropolitan areaJ Weissman, A M Epstein
Hypertension (Dallas, Tex. : 1979)|June 16, 2001
Arterial calcification and calcium antagonists: what does it mean?M Epstein, H R Black
Molecular & Cellular Oncology|November 25, 2020
Tumorigenic de-differentiation: the alternative splicing wayDebleena Ray, David M Epstein
Heartrhythm Case Reports|May 7, 2020
Author's Reply-Is it really COVID-19?David Chang, Laurence M Epstein
The Journal of Innovations in Cardiac Rhythm Management|June 5, 2020
Strategies for Transvenous Lead Extraction ProceduresLaurence M Epstein, Melanie Maytin
Journal of Hypertension|February 12, 1998
Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal diseaseR A Preston, M Epstein
JAMA|November 6, 1987
Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramineG Oster, A M Epstein
Heartrhythm Case Reports|May 12, 2017
ICD lead abandonment is without risk? A case of "lead on lead crime"Jacques Rizkallah, Laurence M Epstein
Heart (British Cardiac Society)|February 8, 2011
The challenges of transvenous lead extractionMelanie Maytin, Laurence M Epstein
Pageof 187